IDEAYA Biosciences, Inc. SEC filings IDYA

IDEAYA Biosciences, Inc. has 506 filings in SEC EDGAR's recent list, going back to Aug 26, 2016. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.

IDEAYA Biosciences, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Nov 3, 2026 —
10-Q Quarterly report Nov 3, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 3, 2026 Nov 3, 2026
4 Insider transaction Oct 8, 2026 Oct 6, 2026
144 Notice of proposed sale Oct 6, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2026 —
10-Q Quarterly report Aug 4, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 4, 2026 Aug 4, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 31, 2026 —
4 Insider transaction Jul 9, 2026 Jul 7, 2026
144 Notice of proposed sale Jul 7, 2026 —
8-K Current report
Shareholder vote results, Other events
Jun 23, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
8-K Current report
Other events
Jun 10, 2026 Jun 8, 2026
424B5 Prospectus supplement Jun 9, 2026 —
424B5 Prospectus supplement Jun 8, 2026 —
3 Initial insider ownership Jun 5, 2026 Mar 18, 2026
8-K Current report
Other events
Jun 3, 2026 Jun 3, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 1, 2026 Jun 1, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
8-K Current report
Other events
May 5, 2026 May 5, 2026
424B5 Prospectus supplement May 5, 2026 —
S-3ASR Automatic shelf registration May 5, 2026 —
10-Q Quarterly report May 5, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
DEFA14A Additional proxy material Apr 30, 2026 —
DEF 14A Proxy statement Apr 29, 2026 Jun 16, 2026
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
8-K Current report
Other events
Apr 13, 2026 Apr 13, 2026
8-K Current report
Other events
Apr 9, 2026 Apr 8, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 2, 2026 Mar 2, 2026
S-8 Employee stock plan registration Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
10-K Annual report Feb 17, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 17, 2026 Feb 17, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2026 —
4 Insider transaction Feb 2, 2026 Jan 30, 2026
4 Insider transaction Feb 2, 2026 Jan 30, 2026
4 Insider transaction Feb 2, 2026 Jan 30, 2026
4 Insider transaction Feb 2, 2026 Jan 30, 2026
4 Insider transaction Feb 2, 2026 Jan 30, 2026
4 Insider transaction Feb 2, 2026 Jan 30, 2026
4 Insider transaction Feb 2, 2026 Jan 30, 2026
8-K Current report
Other events
Jan 12, 2026 Jan 11, 2026
8-K Current report
Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 8, 2026 —
8-K Current report
Agreement ended
Dec 12, 2025 Dec 9, 2025
8-K Current report
Other events
Dec 5, 2025 Dec 4, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
8-K Current report
Other events
Oct 20, 2025 Oct 17, 2025
8-K Current report
Other events
Sep 8, 2025 Sep 7, 2025
8-K Current report
Material agreement
Sep 2, 2025 Aug 29, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 13, 2025 —
S-8 Employee stock plan registration Aug 5, 2025 —
10-Q Quarterly report Aug 5, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
3 Initial insider ownership Jun 27, 2025 Jun 27, 2025
8-K Current report
Officer or director change
Jun 27, 2025 Jun 26, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
8-K Current report
Shareholder vote results
Jun 24, 2025 Jun 24, 2025
SCHEDULE 13G Ownership over 5% (passive) Jun 9, 2025 —
ARS Annual report to shareholders May 20, 2025 Dec 31, 2024
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2025 —
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
DEF 14A Proxy statement Apr 30, 2025 Jun 24, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 17, 2025 —
8-K Current report
Officer or director change
Apr 2, 2025 Mar 28, 2025
4 Insider transaction Feb 28, 2025 Feb 27, 2025
4 Insider transaction Feb 28, 2025 Feb 27, 2025
4 Insider transaction Feb 28, 2025 Feb 27, 2025
4 Insider transaction Feb 28, 2025 Feb 27, 2025
4 Insider transaction Feb 28, 2025 Feb 27, 2025
4 Insider transaction Feb 28, 2025 Feb 27, 2025
4 Insider transaction Feb 19, 2025 Feb 18, 2025
S-8 Employee stock plan registration Feb 18, 2025 —
10-K Annual report Feb 18, 2025 Dec 31, 2024
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
8-K Current report
Results of operations
Feb 13, 2025 Feb 13, 2025
8-K Current report
Officer or director change
Feb 10, 2025 Feb 10, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2025 —
8-K Current report
Material agreement
Dec 30, 2024 Dec 27, 2024
3 Initial insider ownership Dec 20, 2024 Dec 11, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
10-Q Quarterly report Nov 4, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 4, 2024 Nov 4, 2024
8-K Current report
Other events
Oct 25, 2024 Oct 25, 2024
8-K Current report
Other events
Oct 4, 2024 Oct 4, 2024
4 Insider transaction Sep 27, 2024 Sep 26, 2024
3 Initial insider ownership Sep 27, 2024 Sep 18, 2024
8-K Current report
Other events
Sep 23, 2024 Sep 23, 2024
144 Notice of proposed sale Aug 26, 2024 —
S-8 Employee stock plan registration Aug 6, 2024 —
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
10-Q/A Amended quarterly report Aug 6, 2024 Mar 31, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
8-K Current report
Material agreement
Jul 31, 2024 Jul 30, 2024
8-K Current report
Other events
Jul 11, 2024 Jul 9, 2024
424B5 Prospectus supplement Jul 10, 2024 —
424B5 Prospectus supplement Jul 9, 2024 —
8-K Current report
Results of operations, Other events
Jul 9, 2024 Jul 9, 2024
8-K Current report
Other events
Jul 8, 2024 Jul 8, 2024
4 Insider transaction Jun 27, 2024 Jun 27, 2024
8-K Current report
Officer or director change
Jun 27, 2024 Jun 21, 2024
8-K Current report
Other events
Jun 3, 2024 Jun 3, 2024
8-K Current report
Shareholder vote results
May 31, 2024 May 31, 2024
4 Insider transaction May 31, 2024 May 31, 2024
4 Insider transaction May 31, 2024 May 31, 2024
4 Insider transaction May 31, 2024 May 31, 2024
4 Insider transaction May 31, 2024 May 31, 2024
4 Insider transaction May 31, 2024 May 31, 2024
4 Insider transaction May 31, 2024 May 31, 2024
4 Insider transaction May 31, 2024 May 31, 2024
4 Insider transaction May 31, 2024 May 29, 2024
144 Notice of proposed sale May 29, 2024 —
4 Insider transaction May 16, 2024 May 14, 2024
144 Notice of proposed sale May 14, 2024 —
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
ARS Annual report to shareholders Apr 24, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 19, 2024 May 31, 2024
8-K Current report
Material agreement
Mar 12, 2024 Mar 8, 2024
4 Insider transaction Mar 4, 2024 Mar 1, 2024
4 Insider transaction Mar 4, 2024 Mar 1, 2024
4 Insider transaction Mar 4, 2024 Mar 1, 2024
4 Insider transaction Mar 4, 2024 Mar 1, 2024
4 Insider transaction Mar 4, 2024 Mar 1, 2024
S-8 Employee stock plan registration Feb 20, 2024 —
10-K Annual report Feb 20, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 20, 2024 Feb 20, 2024
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G Ownership over 5% (passive) Feb 13, 2024 —
4 Insider transaction Feb 13, 2024 Feb 9, 2024
4 Insider transaction Feb 12, 2024 Feb 8, 2024
SC 13G Ownership over 5% (passive) Feb 12, 2024 —
144 Notice of proposed sale Feb 9, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 7, 2024 —
4 Insider transaction Feb 5, 2024 Feb 1, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 1, 2024 —
144 Notice of proposed sale Feb 1, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 25, 2024 —
4 Insider transaction Jan 24, 2024 Jan 22, 2024
8-K Current report
Other events
Jan 23, 2024 Jan 22, 2024
8-K Current report
Material agreement
Jan 19, 2024 Jan 19, 2024
424B5 Prospectus supplement Jan 19, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 18, 2024 —
4 Insider transaction Jan 17, 2024 Jan 12, 2024
4 Insider transaction Jan 17, 2024 Jan 12, 2024
8-K Current report
Other events
Jan 16, 2024 Jan 12, 2024
144 Notice of proposed sale Jan 12, 2024 —
144 Notice of proposed sale Jan 12, 2024 —
8-K Current report
Other events
Jan 12, 2024 Jan 4, 2024
144 Notice of proposed sale Dec 27, 2023 —
4 Insider transaction Dec 19, 2023 Dec 15, 2023
4 Insider transaction Dec 19, 2023 Dec 15, 2023
4 Insider transaction Dec 18, 2023 Dec 14, 2023
144 Notice of proposed sale Dec 15, 2023 —
144 Notice of proposed sale Dec 15, 2023 —
144 Notice of proposed sale Dec 14, 2023 —
144 Notice of proposed sale Dec 11, 2023 —
144 Notice of proposed sale Dec 4, 2023 —
8-K Current report
Material agreement
Dec 4, 2023 Nov 29, 2023
144 Notice of proposed sale Nov 28, 2023 —
144 Notice of proposed sale Nov 27, 2023 —
8-K Current report
Material agreement
Nov 17, 2023 Nov 14, 2023
4 Insider transaction Nov 7, 2023 Nov 3, 2023
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
8-K Current report
Other events
Oct 27, 2023 Oct 24, 2023
424B5 Prospectus supplement Oct 26, 2023 —
424B5 Prospectus supplement Oct 24, 2023 —
8-K Current report
Results of operations, Other events
Oct 24, 2023 Oct 24, 2023
8-K Current report
Other events
Oct 23, 2023 Oct 23, 2023
8-K Current report
Officer or director change
Sep 26, 2023 Sep 21, 2023
4 Insider transaction Sep 14, 2023 Sep 12, 2023
4 Insider transaction Sep 6, 2023 Sep 1, 2023
4 Insider transaction Sep 6, 2023 Sep 1, 2023
144 Notice of proposed sale Sep 1, 2023 —
4 Insider transaction Aug 31, 2023 Aug 29, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IDYA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Large accelerated filer
SEC CIK
1676725

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.